Magnetic resonance examination to predict pathological complete response following neoadjuvant chemotherapy: when is it appropriate for HER2-positive and triple-negative breast cancers?
Crossref DOI link: https://doi.org/10.1007/s12282-015-0642-7
Published Online: 2015-10-05
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Okamoto, Satoko
Yamada, Takayuki
Kanemaki, Yoshihide
Kojima, Yasuyuki
Tsugawa, Koichiro
Nakajima, Yasuo
Text and Data Mining valid from 2015-10-05